Home / News / Doubt over result in Towers-Willis merger countdown

Doubt over result in Towers-Willis merger countdown

News

With just days to go before the crucial vote on the US$18 billion merger of global asset consultant Towers Watson and big insurance broker Willis, doubt has been cast over the result. The two largest proxy voting firms and at least one fund manager are urging a ‘no’ vote.
The vote, on November 18 (US eastern time) in Miami, Florida, is of the Towers Watson shareholders – Towers being a NASDAQ-listed company since its previous merger between the old Watson Wyatt and Towers Perrin. Willis shareholders – whose company is NYSE listed – will own 50.1 per cent of a merged group under the current proposal.
Shareholders and their advisors went public last week with a slanging match between the ‘yes’ and ‘no’ camps. Towers Watson has reaffirmed its commitment to the deal, which will form the third-largest investment and insurance advisory and financial product company in the world.
The proxy-vote agencies Institutional Shareholder Services (ISS) and Glass, Lewis & Co recommended voters reject the offer, as did fund manager Driehaus Capital. “Although the potential long-term benefits of the deal appear compelling, it is not at all clear that realizing those opportunities necessitates taking a steep discount,” ISS stated in a report. Asset International, an investment media group, reported that ISS critiqued Towers for negotiating exclusively with Willis as opposed to putting itself in play for other bids.
Towers shot back the next day, Asset International reported. The proxy advisors, it argued, “focus on short-term trading, take a narrow view of relative value contribution, and unduly discount the significant long-term value creation potential of the proposed merger with Willis.”
Meanwhile, activist fund manager ValueAct took aim at Driehaus Capital’s assessment that the merger arrangements were “value destructive”. ValueAct said: “It is a shame that ISS could cause the dissolution of a deal that even it doesn’t dispute should be highly accretive to both sets of stockholders over a multi-year time horizon… The suggestion that the Towers Watson board did not do its job in exploring a quick-hit cash premium rings hollow.”  ValueAct accused ISS of “bumpitrage”, which is an attempt to get a short-term stock price bump rather than longer-term value.
Smaller proxy-vote advisors Proxy Mosaic and Egan-Jones announced last week they had recommended clients vote in favour of the merger.

Investor Strategy News




  • Print Article

    Related
    APRA’s governance move could trigger wholesale change

    If the regulator’s proposal to limit board tenure to 10 years takes effect, then many non-executive board members will be in the firing line, with industry funds likely to have the most casualties.

    Nicholas Way | 7th Mar 2025 | More
    ATO has family offices in its sights over succession strategies

    The wealth transfer from Baby Boomers to their offspring, which is in full swing, has got the taxman’s full attention, especially as it pertains to capital gains payments, trust structures and potential breaches of the Tax Act’s Division 7A.

    Duncan Hughes | 27th Feb 2025 | More
    Don’t fear the ‘Trump effect’ in emerging markets: Ninety One

    The set-up for emerging markets is better than ever, and harks back to the beginning of their decade-long run following the end of the Asian financial crisis. And while Trump has investors running scared, fears about another brushfire trade war are overblown.

    Lachlan Maddock | 21st Feb 2025 | More
    Popular